NEW YORK – Armonica Technologies, a University of New Mexico spinout commercializing a nanopore DNA sequencing method, said on Monday it has received a two-year Small Business Innovation Research Phase I grant from the National Human Genome Research Institute.
Armonica will receive $349,200 in fiscal year 2021. The Albuquerque, New Mexico-based company is partnering with UNM researcher and Cofounder Jeremy Edwards as part of the award.
Using nanochannels that help capture optical spectra of DNA molecules based on the principle of Raman scattering, Armonica's technology can generate long reads of single molecules, including direct readout of epigenetic modifications.
"Armonica continues to make significant improvements to the performance of our groundbreaking technology, and we are honored that the NIH has awarded us this grant in support of our product development goals," CEO Victor Esch said in a statement.
The grant adds to $1.5 million in seed funding from New Mexico's Catalyst Fund.